Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women
NCT ID: NCT06116201
Last Updated: 2023-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2020-08-15
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transgender women with orchiectomy
Transgender women who took medication for sex transition form male to female via estradiol hormone therapy and orchiectomy surgery. They were recruited for measurement of all variables in the study to compare with another group.
Estradiol
Estradiol
Transgender women without orchiectomy
Transgender women who took medication for sex transition form male to female via estradiol hormone and anti-androgen hormone therapy. They were recruited for measurement of all variables in the study to compare with another group.
Estradiol and Anti-Androgen
Estradiol and Anti-Androgen
Cisgender men
Cisgender men who lived in normal life were not used medication process for sex transition. They were recruited for measurement of all variables in the study to compare with another group.
No intervention
No intervention
Cisgender women
Cisgender women who lived in normal life were not used medication process for sex transition. They were recruited for measurement of all variables in the study to compare with another group.
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Estradiol
Estradiol
Estradiol and Anti-Androgen
Estradiol and Anti-Androgen
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Cisgender women group (Body mass index between 18.5-24.9, No pregnant, NO NCDs).
3. Transgender women with orchiectomy (Body mass index between 18.5-24.9, taking estradiol, testosterone level below 10 nmol/L, NO NCDs).
4. Transgender women without orchiectomy (Body mass index between 18.5-24.9, taking estradiol and anti-androgen, testosterone level below 10 nmol/L, NO NCDs).
Exclusion Criteria
20 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr.Daroonwan Suksom
Faculty of Sports Science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daroonwan Suksom, Ph.D.
Role: STUDY_DIRECTOR
Chulalongkorn University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Sports Science, Chulalongkorn University
Pathum Wan, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Saitong A, Naeowong W, Suksom D, Tanaka H. Physical Fitness and Exercise Performance of Transgender Women. Med Sci Sports Exerc. 2025 Jan 1;57(1):134-143. doi: 10.1249/MSS.0000000000003536. Epub 2024 Aug 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPSC-7
Identifier Type: -
Identifier Source: org_study_id